A modified whole blood partial thromboplastin test for the assessment of heparinization.
作者信息
Ray P K, Abbott D
出版信息
Can Med Assoc J. 1973 Jun 23;108(12):1505-8.
Abstract
Current methods of assessment of heparinization are either inconvenient as bedside procedures or lack correlation with the Lee-White whole blood clotting time over the therapeutic range. A new thromboplastin time (CAT time) has been developed to overcome these disadvantages by offering uniform contact activation. The test makes use of a partial thromboplastin activated by celite-adsorbed "contact factor", thus eliminating the activation phase of the activated partial thromboplastin time. Preliminary experiments suggest that this modification will be helpful in the study of "contact factor" deficiencies.
摘要
相似文献
1
A modified whole blood partial thromboplastin test for the assessment of heparinization.
Can Med Assoc J. 1973 Jun 23;108(12):1505-8.
2
Whole-blood clotting time, activated partial thromboplastin time, and whole-blood recalcification time as heparin monitoring tests.全血凝固时间、活化部分凝血活酶时间和全血复钙时间作为肝素监测指标。
Am J Clin Pathol. 1979 Jan;71(1):17-21. doi: 10.1093/ajcp/71.1.17.
3
A simplified method for monitoring heparin therapy at the bedside: the activated whole blood clotting time.
Am J Hematol. 1981 Nov;11(3):277-81. doi: 10.1002/ajh.2830110308.
4
Monitoring heparin therapy with the activated partial thromboplastin time.
Can Med Assoc J. 1971 Mar 6;104(5):385-8.
5
The activated partial thromboplastin time in the control of heparin treatment.
Australas Ann Med. 1970 Nov;19(4):334-7. doi: 10.1111/imj.1970.19.4.334.
6
Clotting, activated partial thromboplastin and coagulation times in monitoring heparin therapy.在监测肝素治疗时的凝血、活化部分凝血活酶时间和凝血时间。
Ann Clin Lab Sci. 1979 Nov-Dec;9(6):494-500.
7
[Laboratory control of anticoagulant treatments (author's transl)].抗凝治疗的实验室控制（作者译）
J Mal Vasc. 1981;6(4):257-61.
8
Heparin therapy: a simpler test of control.肝素治疗：一种更简单的控制检测方法。
J Clin Pathol. 1974 Mar;27(3):250-2. doi: 10.1136/jcp.27.3.250.
9
Relationship of the partial thromboplastin time to the Lee-White coagulation time.
Tech Bull Regist Med Technol. 1968 Aug;38(8):223-7.
10
[Monitoring of heparin therapy in thromboembolism].
Dtsch Med Wochenschr. 1973 Jul;98(28):1367-70. doi: 10.1055/s-0028-1107032.
本文引用的文献
1
The role of Hageman factor in the initiation of blood coagulation.哈格曼因子在血液凝固起始过程中的作用。
Br J Haematol. 1959 Apr;5(2):203-11. doi: 10.1111/j.1365-2141.1959.tb04026.x.
2
Contact activation in the intrinsic blood clotting system; studies on a plasma product formed on contact with glass and similar surfaces.
Scand J Clin Lab Invest. 1959;11 Supp 37:1-133.
3
The recalcification time of blood; its use as a measure of the clinical effect of heparin.
AMA Arch Surg. 1958 Feb;76(2):210-8. doi: 10.1001/archsurg.1958.01280200032004.
4
Clotting factor assays on plasma from patients receiving intramuscular of subcutaneous heparin.
Am J Med Sci. 1957 Dec;234(6):678-86. doi: 10.1097/00000441-195712000-00006.
5
Use of the activated partial thromboplastin time in the control of heparin administration.
Clin Chem. 1966 May;12(5):263-8.
6
Control of heparin therapy. Sensitivity of the activated partial thromboplastin time for monitoring the antithrombotic effects of heparin.
J Lab Clin Med. 1969 Feb;73(2):320-6.
7
A rapid bedside method for the control of heparin therapy.
Can Med Assoc J. 1968 Dec 7;99(22):1072-6.
8
Improved coagulation screening by an activated recalcification test.
J Clin Pathol. 1967 May;20(3):244-8. doi: 10.1136/jcp.20.3.244.
9
Comparison of activated recalcification and partial thromboplastin tests as controls of heparin therapy.
J Lab Clin Med. 1971 Jun;77(6):901-7.
10
Laboratory control of heparin therapy with the activated partial thromboplastin time test.
Curr Ther Res Clin Exp. 1969 Jun;11(6):390-6.
Zotero 插件